Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers

•Rotenone induced α-synuclein (aSyn) aggregation in [A53T]aSyn overexpressing cells.•Prolyl oligopeptidase (PREP) inhibition reduced the levels of aSyn oligomers.•PREP inhibition decreased ROS production by reducing aSyn oligomers.•These effects of PREP inhibition led to increased cell survival. α-S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2014-11, Vol.583, p.37-42
Hauptverfasser: Dokleja, Lana, Hannula, Mirva J., Myöhänen, Timo T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue
container_start_page 37
container_title Neuroscience letters
container_volume 583
creator Dokleja, Lana
Hannula, Mirva J.
Myöhänen, Timo T.
description •Rotenone induced α-synuclein (aSyn) aggregation in [A53T]aSyn overexpressing cells.•Prolyl oligopeptidase (PREP) inhibition reduced the levels of aSyn oligomers.•PREP inhibition decreased ROS production by reducing aSyn oligomers.•These effects of PREP inhibition led to increased cell survival. α-Synuclein (aSyn) aggregation, mitochondrial dysfunction and oxidative damage has been shown to be related to the death of dopaminergic neurons in Parkinson's disease (PD). Prolyl oligopeptidase (PREP) is proposed to increase aSyn aggregation, and PREP inhibition has been shown to inhibit the aggregation process in vitro and in vivo. In this study, we investigated the effects of a specific PREP inhibitor, KYP-2047, on rotenone induced aSyn aggregation and increased the production of reactive oxygen species (ROS) in cells overexpressing A53T mutation of aSyn. Rotenone, a mitochondrial toxin that induces oxidative damage and aSyn aggregation, associated with PD pathology, was selected as a model for this study. The results showed that rotenone induced the formation of high-molecular-weight aSyn oligomers, and this was countered by simultaneous incubation with KYP-2047. Inhibition of PREP also decreased the production of ROS in [A53T]aSyn overexpressing cells, leading to improved cell viability.
doi_str_mv 10.1016/j.neulet.2014.09.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1635034746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394014007630</els_id><sourcerecordid>1629966847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-f532a06ef599050de462f84a366b4c61c0e0d277f2863cd1cf57b4da37f12b33</originalsourceid><addsrcrecordid>eNqNkc-KFDEQh4Mo7rj6BiI5eumx8qfT0xdBllUXFrzsPaTTlZ0MmaRNugfnbXxU08zqRRBPKchXvyrqI-Qtgy0Dpj4cthGXgPOWA5Nb6LfA1TOyYbuON13f8edkAwJkI3oJV-RVKQcAaFkrX5Ir3nIJbc835Odd3PvBzz5FmhydcgrnQFPwj2nCafajKUh9tBlrUei8R1qWfPInE1behGlvmnKOiw3oa8QJM_6YMpbi4yO1GEKhxs2YaU4zxhSR1v9UM5AOZ5pxXOxK_hW0bnDEXF6TF86Egm-e3mvy8Pn24eZrc__ty93Np_vGSsXmxrWCG1Do2r6HFkaUirudNEKpQVrFLCCMvOsc3ylhR2Zd2w1yNKJzjA9CXJP3l9h6ge8LllkffVnXNxHTUjRTogUhO6n-A-V9r9ROdhWVF9TmVEpGp6fsjyafNQO9WtQHfbGoV4sael0t1rZ3TxOW4Yjjn6bf2irw8QJgvcjJY9bFeowWR5_RznpM_t8TfgGLk7UC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629966847</pqid></control><display><type>article</type><title>Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dokleja, Lana ; Hannula, Mirva J. ; Myöhänen, Timo T.</creator><creatorcontrib>Dokleja, Lana ; Hannula, Mirva J. ; Myöhänen, Timo T.</creatorcontrib><description>•Rotenone induced α-synuclein (aSyn) aggregation in [A53T]aSyn overexpressing cells.•Prolyl oligopeptidase (PREP) inhibition reduced the levels of aSyn oligomers.•PREP inhibition decreased ROS production by reducing aSyn oligomers.•These effects of PREP inhibition led to increased cell survival. α-Synuclein (aSyn) aggregation, mitochondrial dysfunction and oxidative damage has been shown to be related to the death of dopaminergic neurons in Parkinson's disease (PD). Prolyl oligopeptidase (PREP) is proposed to increase aSyn aggregation, and PREP inhibition has been shown to inhibit the aggregation process in vitro and in vivo. In this study, we investigated the effects of a specific PREP inhibitor, KYP-2047, on rotenone induced aSyn aggregation and increased the production of reactive oxygen species (ROS) in cells overexpressing A53T mutation of aSyn. Rotenone, a mitochondrial toxin that induces oxidative damage and aSyn aggregation, associated with PD pathology, was selected as a model for this study. The results showed that rotenone induced the formation of high-molecular-weight aSyn oligomers, and this was countered by simultaneous incubation with KYP-2047. Inhibition of PREP also decreased the production of ROS in [A53T]aSyn overexpressing cells, leading to improved cell viability.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2014.09.026</identifier><identifier>PMID: 25240592</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>alpha-Synuclein - genetics ; alpha-Synuclein - metabolism ; Autophagy ; Cell Line, Tumor ; Humans ; Mitochondria - metabolism ; Mutation ; Parkinson's disease ; Proline - analogs &amp; derivatives ; Proline - pharmacology ; Protein Aggregates ; Protein misfolding ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Rotenone - toxicity ; Serine Endopeptidases - metabolism ; Serine protease ; Serine Proteinase Inhibitors - pharmacology ; Solubility</subject><ispartof>Neuroscience letters, 2014-11, Vol.583, p.37-42</ispartof><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-f532a06ef599050de462f84a366b4c61c0e0d277f2863cd1cf57b4da37f12b33</citedby><cites>FETCH-LOGICAL-c461t-f532a06ef599050de462f84a366b4c61c0e0d277f2863cd1cf57b4da37f12b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304394014007630$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25240592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dokleja, Lana</creatorcontrib><creatorcontrib>Hannula, Mirva J.</creatorcontrib><creatorcontrib>Myöhänen, Timo T.</creatorcontrib><title>Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>•Rotenone induced α-synuclein (aSyn) aggregation in [A53T]aSyn overexpressing cells.•Prolyl oligopeptidase (PREP) inhibition reduced the levels of aSyn oligomers.•PREP inhibition decreased ROS production by reducing aSyn oligomers.•These effects of PREP inhibition led to increased cell survival. α-Synuclein (aSyn) aggregation, mitochondrial dysfunction and oxidative damage has been shown to be related to the death of dopaminergic neurons in Parkinson's disease (PD). Prolyl oligopeptidase (PREP) is proposed to increase aSyn aggregation, and PREP inhibition has been shown to inhibit the aggregation process in vitro and in vivo. In this study, we investigated the effects of a specific PREP inhibitor, KYP-2047, on rotenone induced aSyn aggregation and increased the production of reactive oxygen species (ROS) in cells overexpressing A53T mutation of aSyn. Rotenone, a mitochondrial toxin that induces oxidative damage and aSyn aggregation, associated with PD pathology, was selected as a model for this study. The results showed that rotenone induced the formation of high-molecular-weight aSyn oligomers, and this was countered by simultaneous incubation with KYP-2047. Inhibition of PREP also decreased the production of ROS in [A53T]aSyn overexpressing cells, leading to improved cell viability.</description><subject>alpha-Synuclein - genetics</subject><subject>alpha-Synuclein - metabolism</subject><subject>Autophagy</subject><subject>Cell Line, Tumor</subject><subject>Humans</subject><subject>Mitochondria - metabolism</subject><subject>Mutation</subject><subject>Parkinson's disease</subject><subject>Proline - analogs &amp; derivatives</subject><subject>Proline - pharmacology</subject><subject>Protein Aggregates</subject><subject>Protein misfolding</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Rotenone - toxicity</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Serine protease</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Solubility</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc-KFDEQh4Mo7rj6BiI5eumx8qfT0xdBllUXFrzsPaTTlZ0MmaRNugfnbXxU08zqRRBPKchXvyrqI-Qtgy0Dpj4cthGXgPOWA5Nb6LfA1TOyYbuON13f8edkAwJkI3oJV-RVKQcAaFkrX5Ir3nIJbc835Odd3PvBzz5FmhydcgrnQFPwj2nCafajKUh9tBlrUei8R1qWfPInE1behGlvmnKOiw3oa8QJM_6YMpbi4yO1GEKhxs2YaU4zxhSR1v9UM5AOZ5pxXOxK_hW0bnDEXF6TF86Egm-e3mvy8Pn24eZrc__ty93Np_vGSsXmxrWCG1Do2r6HFkaUirudNEKpQVrFLCCMvOsc3ylhR2Zd2w1yNKJzjA9CXJP3l9h6ge8LllkffVnXNxHTUjRTogUhO6n-A-V9r9ROdhWVF9TmVEpGp6fsjyafNQO9WtQHfbGoV4sael0t1rZ3TxOW4Yjjn6bf2irw8QJgvcjJY9bFeowWR5_RznpM_t8TfgGLk7UC</recordid><startdate>20141107</startdate><enddate>20141107</enddate><creator>Dokleja, Lana</creator><creator>Hannula, Mirva J.</creator><creator>Myöhänen, Timo T.</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20141107</creationdate><title>Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers</title><author>Dokleja, Lana ; Hannula, Mirva J. ; Myöhänen, Timo T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-f532a06ef599050de462f84a366b4c61c0e0d277f2863cd1cf57b4da37f12b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>alpha-Synuclein - genetics</topic><topic>alpha-Synuclein - metabolism</topic><topic>Autophagy</topic><topic>Cell Line, Tumor</topic><topic>Humans</topic><topic>Mitochondria - metabolism</topic><topic>Mutation</topic><topic>Parkinson's disease</topic><topic>Proline - analogs &amp; derivatives</topic><topic>Proline - pharmacology</topic><topic>Protein Aggregates</topic><topic>Protein misfolding</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Rotenone - toxicity</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Serine protease</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dokleja, Lana</creatorcontrib><creatorcontrib>Hannula, Mirva J.</creatorcontrib><creatorcontrib>Myöhänen, Timo T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dokleja, Lana</au><au>Hannula, Mirva J.</au><au>Myöhänen, Timo T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2014-11-07</date><risdate>2014</risdate><volume>583</volume><spage>37</spage><epage>42</epage><pages>37-42</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><abstract>•Rotenone induced α-synuclein (aSyn) aggregation in [A53T]aSyn overexpressing cells.•Prolyl oligopeptidase (PREP) inhibition reduced the levels of aSyn oligomers.•PREP inhibition decreased ROS production by reducing aSyn oligomers.•These effects of PREP inhibition led to increased cell survival. α-Synuclein (aSyn) aggregation, mitochondrial dysfunction and oxidative damage has been shown to be related to the death of dopaminergic neurons in Parkinson's disease (PD). Prolyl oligopeptidase (PREP) is proposed to increase aSyn aggregation, and PREP inhibition has been shown to inhibit the aggregation process in vitro and in vivo. In this study, we investigated the effects of a specific PREP inhibitor, KYP-2047, on rotenone induced aSyn aggregation and increased the production of reactive oxygen species (ROS) in cells overexpressing A53T mutation of aSyn. Rotenone, a mitochondrial toxin that induces oxidative damage and aSyn aggregation, associated with PD pathology, was selected as a model for this study. The results showed that rotenone induced the formation of high-molecular-weight aSyn oligomers, and this was countered by simultaneous incubation with KYP-2047. Inhibition of PREP also decreased the production of ROS in [A53T]aSyn overexpressing cells, leading to improved cell viability.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25240592</pmid><doi>10.1016/j.neulet.2014.09.026</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2014-11, Vol.583, p.37-42
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_1635034746
source MEDLINE; Elsevier ScienceDirect Journals
subjects alpha-Synuclein - genetics
alpha-Synuclein - metabolism
Autophagy
Cell Line, Tumor
Humans
Mitochondria - metabolism
Mutation
Parkinson's disease
Proline - analogs & derivatives
Proline - pharmacology
Protein Aggregates
Protein misfolding
Reactive oxygen species
Reactive Oxygen Species - metabolism
Rotenone - toxicity
Serine Endopeptidases - metabolism
Serine protease
Serine Proteinase Inhibitors - pharmacology
Solubility
title Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A24%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20prolyl%20oligopeptidase%20increases%20the%20survival%20of%20alpha-synuclein%20overexpressing%20cells%20after%20rotenone%20exposure%20by%20reducing%20alpha-synuclein%20oligomers&rft.jtitle=Neuroscience%20letters&rft.au=Dokleja,%20Lana&rft.date=2014-11-07&rft.volume=583&rft.spage=37&rft.epage=42&rft.pages=37-42&rft.issn=0304-3940&rft.eissn=1872-7972&rft_id=info:doi/10.1016/j.neulet.2014.09.026&rft_dat=%3Cproquest_cross%3E1629966847%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629966847&rft_id=info:pmid/25240592&rft_els_id=S0304394014007630&rfr_iscdi=true